| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012272855 |
| P356 | DOI | 10.1007/S11060-009-9967-4 |
| P932 | PMC publication ID | 2811648 |
| P698 | PubMed publication ID | 19644652 |
| P5875 | ResearchGate publication ID | 26707247 |
| P50 | author | Veit Rohde | Q33303720 |
| P2093 | author name string | Gabriele Schackert | |
| Ramon Martinez | |||
| P2860 | cites work | Comprehensive genomic characterization defines human glioblastoma genes and core pathways | Q24656128 |
| MGMT gene silencing and benefit from temozolomide in glioblastoma | Q27824832 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome | Q29615538 | ||
| Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide | Q33341259 | ||
| Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery | Q33483488 | ||
| Mutations of the human PTEN gene | Q33988995 | ||
| Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas | Q34428834 | ||
| Classification of glioblastoma multiforme in adults by molecular genetics | Q35144463 | ||
| p53, mdm2, EGFR, and msh2 expression in paired initial and recurrent glioblastoma multiforme | Q35473890 | ||
| Molecular-genetic characterisation of gliomas that recur as same grade or higher grade tumours | Q35572577 | ||
| Genetic pathways to primary and secondary glioblastoma | Q35757144 | ||
| Frequency of allele loss of DCC, p53, RBI, WT1, NF1, NM23 and APC/MCC in colorectal cancer assayed by fluorescent multiplex polymerase chain reaction | Q36080181 | ||
| Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma | Q36610148 | ||
| Reliability of differential PCR for the detection of EGFR and MDM2 gene amplification in DNA extracted from FFPE glioma tissue. | Q38481936 | ||
| Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3. | Q40143844 | ||
| The codon 72 polymorphic variants of p53 have markedly different apoptotic potential | Q40672888 | ||
| Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis | Q40694250 | ||
| Inactivation of MMAC1 in bladder transitional-cell carcinoma cell lines and specimens | Q40838626 | ||
| Rare-type mutations of MMAC1 tumor suppressor gene in human glioma cell lines and their tumors of origin | Q40919390 | ||
| Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes | Q41078007 | ||
| Temozolomide as a second-line systemic regimen in recurrent high-grade glioma: a phase II study. | Q43573420 | ||
| Promoter methylation of the DNA repair gene MGMT in astrocytomas is frequently associated with G:C --> A:T mutations of the TP53 tumor suppressor gene | Q43750899 | ||
| Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10. | Q43860454 | ||
| Genetic pathways to glioblastoma: a population-based study | Q44673208 | ||
| Distinct transcription profiles of primary and secondary glioblastoma subgroups. | Q46259525 | ||
| p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity | Q46852327 | ||
| Variation of O(6)-methylguanine-DNA methyltransferase (MGMT) promoter methylation in serial samples in glioblastoma | Q46899315 | ||
| Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines | Q48154511 | ||
| Clonal composition of glioblastoma multiforme | Q48442605 | ||
| Abnormalities of p16, p15 and CDK4 genes in recurrent malignant astrocytomas. | Q48957986 | ||
| CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. | Q53337288 | ||
| A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. | Q54740167 | ||
| Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences. | Q55477117 | ||
| Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors. | Q55481776 | ||
| Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis | Q57240066 | ||
| Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia | Q57240085 | ||
| Identification of a polymorphism in intron 2 of the p53 gene | Q72387836 | ||
| Clonal analysis of human astrocytomas | Q72557780 | ||
| The p53 codon 72 polymorphism and lung cancer risk | Q73112355 | ||
| Protein patterns and proteins that identify subtypes of glioblastoma multiforme | Q80402744 | ||
| Intratumoral homogeneity of MGMT promoter hypermethylation as demonstrated in serial stereotactic specimens from anaplastic astrocytomas and glioblastomas | Q80778839 | ||
| P433 | issue | 3 | |
| P921 | main subject | glioblastoma | Q282142 |
| P304 | page(s) | 321-329 | |
| P577 | publication date | 2009-07-31 | |
| P1433 | published in | Journal of Neuro-Oncology | Q15752119 |
| P1476 | title | Different molecular patterns in glioblastoma multiforme subtypes upon recurrence | |
| P478 | volume | 96 |
| Q38797345 | A comprehensive profile of recurrent glioblastoma |
| Q34734481 | ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas |
| Q30432036 | An extensive invasive intracranial human glioblastoma xenograft model: role of high level matrix metalloproteinase 9. |
| Q41194722 | Astrocytoma-associated antigens - IL13Rα2, Fra-1, and EphA2 as potential markers to monitor the status of tumour-derived cell cultures in vitro |
| Q48341770 | Bioinformatics analysis reveals potential candidate drugs for different subtypes of glioma |
| Q48215789 | CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry |
| Q48470503 | Comparative genomic and proteomic analysis of high grade glioma primary cultures and matched tumor in situ |
| Q38171032 | EGFR signaling and autophagy dependence for growth, survival, and therapy resistance |
| Q47973210 | Elastic and inelastic light scattering spectroscopy and its possible use for label-free brain tumor typing. |
| Q35457074 | Ethynyldeoxyuridine (EdU) suppresses in vitro population expansion and in vivo tumor progression of human glioblastoma cells. |
| Q38583655 | Experimental Therapeutic Trial Design for Pediatric Brain Tumors |
| Q63753432 | Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing |
| Q55461027 | Genomic profiling reveals distinctive molecular relapse patterns in IDH1/2 wild-type glioblastoma. |
| Q37807263 | Glioblastoma Stem Cells: A Neuropathologist's View |
| Q92356851 | HJURP knockdown disrupts clonogenic capacity and increases radiation-induced cell death of glioblastoma cells |
| Q42205089 | Human cytomegalovirus and primary intracranial tumours: frequency of tumour infection and lack of correlation with systemic immune anti-viral responses |
| Q24612429 | Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma |
| Q64941338 | Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma. |
| Q45794856 | IndividualizedPath: identifying genetic alterations contributing to the dysfunctional pathways in glioblastoma individuals |
| Q36814374 | MRI manifestions correlate with survival of glioblastoma multiforme patients |
| Q34339843 | Prospective collection of tissue samples at autopsy in children with diffuse intrinsic pontine glioma |
| Q39475779 | Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence. |
| Q42367453 | Pushing the limits of glioma resection using electrophysiologic brain mapping |
| Q49883157 | Recurrent Glioblastomas Exhibit Higher Expression of Biomarkers with Stem-like Properties |
| Q36228558 | Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity |
| Q54637633 | The Nature and Timing of Specific Copy Number Changes in the Course of Molecular Progression in Diffuse Gliomas: Further Elucidation of Their Genetic “Life Story” |
| Q47868509 | The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma |
| Q61810888 | The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas |
| Q37820417 | Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis |
| Q58721237 | Whole-Genome Multi-omic Study of Survival in Patients with Glioblastoma Multiforme |
Search more.